Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ALK-Abelló A/S
With
ITEC Services
Condition:
* persistent moderate to severe HDM allergic rhinitis despite use of symptom-relieving medication
* HDM allergic asthma not well controlled by inhaled corticosteroids and associated with mild to severe HDM allergic rhinitis. Patients' asthma status should be carefully evaluated before the initiation of treatment.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
At the discretion of the investigator, patient who will be prescribed ACARIZAX® in line with the approved Summary of Product Characteristics (SmPC) and who have been informed, after explicit written explanation and willing to participate in the study by signed consent
You may not be if
Patient who did not have 12 months prior inclusion or have an on-going, House Dust Mite (HDM) Allergy Immunotherapy (AIT).
Clareo Health | N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France
